🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 46 of 78

  1. US 8440206

    Methods for producing an immune response to tuberculosis

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8440202

    Induction of an immune response against dengue virus using the prime-boost approach

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8435507

    Prostate-specific antigen-derived MHC class II restricted peptides and their use in vaccines to treat or prevent prostate cancer

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8435979

    Use of imipramine blue and analogs thereof in treating cancers

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8431134

    Use of a pneumococcal P4 peptide for enhancing opsonophagocytosis in response to a pathogen

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8431690

    T cell receptors and related materials and methods of use

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8431176

    Liquid chromatographic fraction of enzymatically polymerized flavonoid as an antioxidant

    Expires Mon Apr 25 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8426379

    POT1 alternative splicing variants

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8426445

    Iminosugars and methods of treating bunyaviral and togaviral diseases

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8426574

    Identification of astrovirus VA1 associated with gastroenteritis in humans

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8426575

    N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8420664

    A3 adenosine receptor allosteric modulators

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8420607

    Anthrax carbohydrates, synthesis and uses thereof

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8420107

    Peptide vaccines against group A streptococci

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8420099

    Chimeric protein for prevention and treatment of HIV infection

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8420072

    Vaccination of sex reversed hybrid tilapia (Oreochromis niloticus x O. aureus) with an inactivated Vibrio vulnificus vaccine

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8420620

    Induced internalization of surface receptors

    Expires Mon Apr 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8415097

    Tumor suppressor gene, p47ING3

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8415456

    Substituted IL-15 polypeptides

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8410063

    N-acetyl mannosamine as a therapeutic agent

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8410292

    Epoxy-guaiane derivatives and treatment of cancer

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8410169

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8409858

    Modular functional peptides for the intracellular delivery of nanoparticles

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8409585

    Method for increasing performance of offspring

    Expires Mon Mar 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8404244

    Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8404818

    Monoclonal antibodies against orthopoxviruses

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8399689

    Chrysophaentin antimicrobial compounds that inhibit FtsZ protein

    Expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8394387

    Recombinant modified Bacillus anthracis protective antigen for use in vaccines

    Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8394411

    Papillomavirus pseudoviruses for detection and therapy of tumors

    Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8394764

    Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

    Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8394762

    Self-decontaminating coatings containing antimicrobial peptides

    Expires Mon Mar 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8388933

    Multimeric protein toxins to target cells having multiple identifying characteristics

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8389495

    Olioodeoxynucleotide and its use to induce an immune response

    Expires Mon Feb 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8383817

    Benztropine compounds and uses thereof

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8383589

    Aegyptin and uses thereof

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8383102

    Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8383133

    Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8383099

    Adoptive cell therapy with young T cells

    Expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8378071

    Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8377637

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-17-3P

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8377450

    Clone of Newcastle disease virus, its manufacture and its application in the medical treatment of cancer

    Expires Mon Feb 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8367058

    Method for bacteriophage delivery and amplification

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8367074

    Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    Expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8361710

    MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer using miR-21

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8361772

    Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8361707

    Methods for detecting a Mycobacterium tuberculosis infection

    Expires Mon Jan 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8357353

    Compositions comprising a UV-absorbing chromophore

    Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8357783

    Human anti-mesothelin monoclonal antibodies

    Expires Mon Jan 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.